These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7090203)

  • 21. Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.
    Navarro JF; Teruel JL; Lasunción MA; Mora-Fernandez C; Ortuño J
    Clin Nephrol; 1998 May; 49(5):303-7. PubMed ID: 9617494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
    Wessel-Aas T; Christophersen B
    Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral vitamin C administration increases lipid peroxidation in hemodialysis patients.
    De Vriese AS; Borrey D; Mahieu E; Claeys I; Stevens L; Vanhaeverbeke A; Roelens M; Langlois MR
    Nephron Clin Pract; 2008; 108(1):c28-34. PubMed ID: 18087169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of the tranquilizer mebicar on lipid metabolism and lipid peroxidation in a rat hypokinesic model].
    Zamakova IE; Salikhova RR; Tagirova TS; Garaev RS; Kamburg RA; Ibragimov OB; Kondrat'eva MB
    Biull Eksp Biol Med; 1996 May; 121(5):535-7. PubMed ID: 8744131
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influence of dialysis membranes on lipid parameters].
    de Précigout V
    Nephrologie; 2000; 21(7):359-60. PubMed ID: 11200611
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
    Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of low molecular weight heparin on lipid parameters in hemodialysis patients.
    Elisaf MS; Bairaktari H; Germanos N; Pappas M; Koulouridis E; Papagalanis N; Siamopoulos KC
    Int Angiol; 1996 Sep; 15(3):252-6. PubMed ID: 8971586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients.
    Soejima A; Matsuzawa N; Miyake N; Karube M; Fukuoka K; Nakabayashi K; Kitamoto K; Nagasawa T
    Clin Nephrol; 1999 Feb; 51(2):92-7. PubMed ID: 10069644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis.
    Samouilidou E; Grapsa E; Karpouza A; Lagouranis A
    Blood Purif; 2007; 25(2):175-8. PubMed ID: 17215574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome].
    Shishkin AN; Kolmakova EV; Ashirova KV
    Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of lipid peroxidation processes in the cytolysis syndrome in viral hepatitis in children].
    Nisevich NI; Uchaĭkin VF; Moleva TP
    Pediatriia; 1978 Jun; (6):44-8. PubMed ID: 673593
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dyslipidemia in patients being treated with peritoneal dialysis].
    Zharfbin A
    Vnitr Lek; 2006 Nov; 52(11):1051-7. PubMed ID: 17165524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysis.
    Gugliucci A; Schulze J; Kinugasa E; Ogata H; Kimura S
    Clin Chim Acta; 2009 Apr; 402(1-2):209-10. PubMed ID: 19150443
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
    Ewers B; Riserus U; Marckmann P
    J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
    Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
    Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.